(Q68059396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference

metastatic colon cancer

1 reference

1 reference

1 reference

C J Punt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

P H de Mulder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

J T Burghouts

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

D J Wagener

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

21 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

326-328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00685954

21 September 2019

exact match

0 references

cites work

Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma

1 reference

12 December 2020

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

12 December 2020

Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma

1 reference

12 December 2020

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture

1 reference

12 December 2020

Chemotherapy of Gastrointestinal Cancer

1 reference

12 December 2020

Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.

1 reference

12 December 2020

Interferon effects upon fluorouracil metabolism by HL-60 cells

1 reference

12 December 2020

Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line

1 reference

12 December 2020

Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil

1 reference

12 December 2020

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

1 reference

12 December 2020

Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells

1 reference

12 December 2020

Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma

1 reference

12 December 2020

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

12 December 2020

Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites

1 reference

12 December 2020

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1537082%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference